Filing Details

Accession Number:
0001770252-21-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-27 21:13:55
Reporting Period:
2021-09-25
Accepted Time:
2021-09-27 21:13:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1770252 Nicole Lambert 320 Wakara Way
Salt Lake City UT 84108
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-09-25 1,311 $33.31 191,610 No 4 F Direct
Common Stock Disposition 2021-09-26 3,426 $33.31 188,184 No 4 F Direct
Common Stock Disposition 2021-09-27 10,112 $33.10 178,072 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 F Direct
No 4 S Direct
Footnotes
  1. Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021.
  2. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.43 to $33.62, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.